DEBRA EMERY: Open Payments
NPI 1164634168 · SETAUKET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$534 in 21 payments from 11 companies in 2025. Trend: 2023 $297 · 2024 $534 · 2025 $534
Food & beverage: $534
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $121 |
| Vanda Pharmaceuticals Inc. | 2 | $79 |
| Alkermes, Inc. | 2 | $60 |
| Corium, LLC | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $28 |
| Lundbeck LLC | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
Products named: COBENFY, ARISTADA, Azstarys, REXULTI, INVEGA SUSTENNA, FANAPT, HETLIOZ, Auvelity.
Industry payments across NY — which companies pay providers there.
